BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) today reported its financial results for the first quarter of 2009. The company’s net loss for the quarter improved to $10.7 million, or $0.22 per diluted share, as compared to $13.1 million, or $0.28 per diluted share, for the first quarter of 2008. The company’s net losses for the first quarter of 2009 and 2008 include non-operating charges of $2.2 million and $3.5 million, respectively, related to other-than-temporary declines in the estimated current fair value of the company’s auction-rate security (ARS) investments.
